文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

腰大池-腹腔分流术与脑室-腹腔分流术治疗特发性颅内高压的比较:基于全国住院患者样本的经济影响和并发症分析

A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample.

作者信息

Menger Richard P, Connor David E, Thakur Jai Deep, Sonig Ashish, Smith Elainea, Guthikonda Bharat, Nanda Anil

机构信息

Department of Neurosurgery, Louisiana State University of Health Sciences; and.

出版信息

Neurosurg Focus. 2014 Nov;37(5):E4. doi: 10.3171/2014.8.FOCUS14436.


DOI:10.3171/2014.8.FOCUS14436
PMID:25363432
Abstract

OBJECT: Complications following lumboperitoneal (LP) shunting have been reported in 18% to 85% of cases. The need for multiple revision surgeries, development of iatrogenic Chiari malformation, and frequent wound complications have prompted many to abandon this procedure altogether for the treatment of idiopathic benign intracranial hypertension (pseudotumor cerebri), in favor of ventriculoperitoneal (VP) shunting. A direct comparison of the complication rates and health care charges between first-choice LP versus VP shunting is presented. METHODS: The Nationwide Inpatient Sample database was queried for all patients with the diagnosis of benign intracranial hypertension (International Classification of Diseases, Ninth Revision, code 348.2) from 2005 to 2009. These data were stratified by operative intervention, with demographic and hospitalization charge data generated for each. RESULTS: A weighted sample of 4480 patients was identified as having the diagnosis of idiopathic intracranial hypertension (IIH), with 2505 undergoing first-time VP shunt placement and 1754 undergoing initial LP shunt placement. Revision surgery occurred in 3.9% of admissions (n = 98) for VP shunts and in 7.0% of admissions (n = 123) for LP shunts (p < 0.0001). Ventriculoperitoneal shunts were placed at teaching institutions in 83.8% of cases, compared with only 77.3% of first-time LP shunts (p < 0.0001). Mean hospital length of stay (LOS) significantly differed between primary VP (3 days) and primary LP shunt procedures (4 days, p < 0.0001). The summed charges for the revisions of 92 VP shunts ($3,453,956) and those of the 6 VP shunt removals ($272,484) totaled $3,726,352 over 5 years for the study population. The summed charges for revision of 70 LP shunts ($2,229,430) and those of the 53 LP shunt removals ($3,125,569) totaled $5,408,679 over 5 years for the study population. CONCLUSIONS: The presented results appear to call into question the selection of LP shunt placement as primary treatment for IIH, as this procedure is associated with a significantly greater likelihood of need for shunt revision, increased LOS, and greater overall charges to the health care system.

摘要

目的:据报道,腰大池腹腔(LP)分流术后并发症发生率在18%至85%之间。由于需要多次翻修手术、医源性Chiari畸形的发生以及频繁的伤口并发症,许多人已完全放弃该手术来治疗特发性良性颅内高压(假性脑瘤),转而青睐脑室腹腔(VP)分流术。本文对首选LP分流术与VP分流术的并发症发生率和医疗费用进行了直接比较。 方法:查询2005年至2009年全国住院患者样本数据库中所有诊断为良性颅内高压(国际疾病分类第九版,代码348.2)的患者。这些数据按手术干预进行分层,并生成了各自的人口统计学和住院费用数据。 结果:加权样本中有4480名患者被诊断为特发性颅内高压(IIH),其中2505例行首次VP分流术,1754例行首次LP分流术。VP分流术入院患者中有3.9%(n = 98)进行了翻修手术,LP分流术入院患者中有7.0%(n = 123)进行了翻修手术(p < 0.0001)。83.8%的VP分流术在教学机构进行,而首次LP分流术仅为77.3%(p < 0.0001)。初次VP分流术(3天)和初次LP分流术的平均住院时间(LOS)有显著差异(4天,p < 0.0001)。研究人群中,92例VP分流术翻修费用(3453956美元)和6例VP分流术移除费用(272484美元)在5年内总计3726352美元。研究人群中,70例LP分流术翻修费用(2229430美元)和53例LP分流术移除费用(3125569美元)在5年内总计5408679美元。 结论:本文结果似乎对选择LP分流术作为IIH的主要治疗方法提出了质疑,因为该手术与分流术翻修的可能性显著增加、住院时间延长以及医疗系统的总体费用增加有关。

相似文献

[1]
A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample.

Neurosurg Focus. 2014-11

[2]
Lumboperitoneal and Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension Demonstrate Comparable Failure and Complication Rates.

Neurosurgery. 2020-2-1

[3]
Treatment of idiopathic intracranial hypertension via stereotactic placement of biventriculoperitoneal shunts.

J Neurosurg. 2018-2-2

[4]
Complications of Ventriculoperitoneal Shunt for Idiopathic Intracranial Hypertension: A Single-Institution Study of 32 Patients.

J Neuroophthalmol. 2021-6-1

[5]
Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension.

Stereotact Funct Neurosurg. 2005

[6]
Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes.

J Neurosurg. 2004-10

[7]
Optimizing ventriculoperitoneal shunt placement in the treatment of idiopathic intracranial hypertension: an analysis of neuroendoscopy, frameless stereotaxy, and intraoperative CT.

Neurosurg Focus. 2016-3

[8]
The effects of lumboperitoneal and ventriculoperitoneal shunts on the cranial and spinal cerebrospinal fluid volume in a patient with idiopathic intracranial hypertension.

Croat Med J. 2016-6-30

[9]
Management of idiopathic intracranial hypertension with a programmable lumboperitoneal shunt: Early experience.

Clin Neurol Neurosurg. 2015-9

[10]
Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension.

J Neuroophthalmol. 2014-9

引用本文的文献

[1]
Integration of continuous lumbar drainage and third-generation EGFR-TKI in managing leptomeningeal metastasis-induced life-threatening intracranial hypertension: a case report.

Front Oncol. 2025-5-30

[2]
Intracranial Hypertension Secondary to Venous Sinus Stenosis by Meningioma: A Case Illustration With Literature Review, Tips for Diagnosis and Management.

Clin Case Rep. 2025-3-24

[3]
Accurate Preoperative and Intraoperative Evaluation Reduces Surgical Costs and Patient Invasiveness in Ventriculoperitoneal Shunt Revision.

Cureus. 2024-6-13

[4]
Development of shunt valves used for treating hydrocephalus: comparison with endoscopy treatment.

Childs Nerv Syst. 2023-10

[5]
Postoperative course of cerebrospinal fluid diversion in the setting of leptomeningeal disease: a systematic review, meta-analysis, and meta-regression with an illustrative case.

J Neurooncol. 2023-5

[6]
Clinical Outcome and Safety of Lumboperitoneal Shunt in the Treatment of Non-Obstructive Hydrocephalus.

Clin Interv Aging. 2023

[7]
Freehand Ventriculoperitoneal Shunt for Idiopathic Intracranial Hypertension: Technical Note for Slit-Like Ventricle Puncture.

Cureus. 2023-2-3

[8]
Lumboperitoneal Shunt Combined With Ommaya Reservoir Enables Continued Intraventricular Chemotherapy for Leptomeningeal Metastasis With Increased Intracranial Pressure.

Brain Tumor Res Treat. 2022-10

[9]
Novel telemetric pressure monitoring in lumbar theca.

Brain Spine. 2022-3-31

[10]
Ventriculoperitoneal Shunt Alone for Cerebrospinal Fluid Rhinorrhea With Neuroendocrine Alterations in Idiopathic Intracranial Hypertension: A Case Report and Literature Review.

Front Neurol. 2022-2-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索